| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 |
| filingDate |
1999-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dfe1afbced442945cb6776cfc4b803d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b2e6c771d1b12e5a0803c90f0aa8757 |
| publicationDate |
2001-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1074259-A1 |
| titleOfInvention |
Preventives for alcoholic gastritis |
| abstract |
A prophylactic drug for the prevention of acutenalcoholic gastritis, comprising a combination of sucralfatenand a histamine H 2 -receptor antagonist, particularlynpreferably famotidine, is disclosed. This prophylactic drugnshows a marked synergistic action in preventing acutenalcoholic gastritis, in comparison with each of thenconstituent drugs being used alone. The combined use of thentwo drugs enables a marked reduction in the respectivennecessary doses. |
| priorityDate |
1998-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |